Amicus Therapeutics Inc. buy StockNews.com
Start price
11.03.23
/
50%
€10.70
Target price
11.03.24
-
Performance (%)
2.80%
End price
12.03.24
€11.00
Summary
This prediction ended on 12.03.24 with a price of €11.00. With a performance of 2.80%, the BUY prediction by StockNews_com for Amicus Therapeutics Inc. closed with a slight gain. StockNews_com has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 1.667% | 1.667% | 36.313% |
| iShares Core DAX® | 0.869% | 2.751% | 22.676% |
| iShares Nasdaq 100 | -0.852% | -2.079% | 4.294% |
| iShares Nikkei 225® | 0.436% | -1.741% | 12.719% |
| iShares S&P 500 | -0.122% | -0.584% | 2.545% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.45
26.10.25
26.10.25
-
26.10.26
26.10.26
61.07%
02.01.26
02.01.26
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.20
16.11.24
16.11.24
-
16.11.25
16.11.25
-11.96%
17.11.25
17.11.25